another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict
.
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�
.
.
.
.
.
.imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�
.